August #62 : Crack the Combination - by Maia Szalavitz

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents

The Miseducation of Nushawn Williams

Smear Tactics

America's Most Unwanted

Stranger Than Fiction

The Bottom Line

Treat Your Cervix Well

Anal Alphabet

Editor's Letter


He The People

All My Children


Skin To Skin

Say What?

Monkey Business

Calling All Dykes

Live Boys!

Cyber HIVerite

One-Man Wonders

Sound Byte

Catching Up With...

The Breakfast Club

21st-Century Fox

Across the Digital Divide

Arch Enemies

The Hole Truth

Cheap Shots

Gimme a Break!

Comfort Zone - August 2000

Lawnmower Man

Sign of the Times

Plantar’s Punch

Herb of the Month - August 2000

Crack the Combination

Damsels in De-Stress

Fire Escape

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

email print

August 2000

Crack the Combination

by Maia Szalavitz

Q: I’ve been positive for three years. My CD4 count is at 400 and falling, so I’ve decided to start antiretroviral treatment. Which drug regimen is best?

Once you’re sure you need the medication, my first consideration is what you can tolerate and whether you will stick to it, since adherence is key to effectiveness. I don’t think any class of drugs has a demonstrated superiority. But my personal preference is to start with one non-nuke (such as efavirenz [Sustiva] or nevirapine [Viramune]) and two nukes. This regimen is better tolerated and has easier dosing than those with protease inhibitors (PIs). It’s not about withholding PIs for some kind of magic later. We’re actually finding that people with high viral loads don’t necessarily do better with PIs than with non-nukes.
Howard Grossman, MD
AIDS specialist, New York City

The conventional wisdom has recently shifted to starting with a combo of non-nukes and nukes rather than PIs. Non-nukes are easier to take—fewer pills—whereas PI-based regimens can be complex (some require changing eating times) and have various toxicities. But our experience is longer with PI-based cocktails: We know they work well and that it’s harder for the virus to develop resistance to the PIs than to the non-nukes. The non-nukes are potent, but if they fail, they fail big-time. I don’t think you can say one approach is clearly better; clinical trials are under way to look at this. The important decision-making factors should include: How high is the viral load? Higher levels might suggest a PI-based combo. Are there social or psychological issues affecting adherence? Lack of stable housing and conditions such as depression can make it tough to stick to a regimen. Are there toxicities that you’re particularly anxious about? Some people don’t mind the low-grade, chronic diarrhea that can come with PIs. Some people worry about the agitation, insomnia and nightmares you can get with Sustiva; former drug users, for example, might have particular problems with this.
Paul Volberding, MD
Director, Positive Health Project, San Francisco

I don’t recommend anything until the patient is ready. The key piece is deciding which combination you can live with over the long term. If you’re worried about adherence to a complex regimen, I would either wait until you can fully commit or consider starting with two drugs: ddI and hydroxyurea. For some people, less is more. With this regimen, pill burden and toxicity are lower, and I find that it’s well tolerated and potent. Plus it maximizes second choices. The patients I have on it have done well—most now have viral loads under 1,000—even though the viral load comes down slower. But I’d only use this combo for people with 400 or more CD4 cells. Interestingly, a recent analysis of studies of triple-combination therapy found that the fewer total pills taken, the greater the viral suppression—regardless of which drugs were used. I also recommend using a multivitamin and a broad array of antioxidants to help protect against the potential toxicity of the drugs.
Richard Elion, MD
AIDS specialist, Washington, DC

This column contains general medical info only. Consult your physician before making treatment decisions. For more info on the government guidelines for combo therapy, click on

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.